34.73 USD
↗ 1.30 (3.89%)AT CLOSE (11:59 AM EDT)
Vericel Corporation
VCELNASDAQ • USD
34.76
↗ 0.00 (0.00%)
POST MARKET (AS OF 04:14 PM EDT)
Post Market
AS OF 04:14 PM EDT
34.76
↗ 0.00 (0.00%)
Market: OPEN
Open?$33.43
High?$35.07
Low?$33.27
Prev. Close?$33.43
Volume?761.4K
Avg. Volume?699.4K
VWAP?$34.41
Rel. Volume?1.09x
Bid / Ask
Bid?$34.70 × 100
Ask?$34.81 × 100
Spread?$0.11
Midpoint?$34.76
Valuation & Ratios
Market Cap?1.8B
Shares Out?50.9M
Float?47.1M
Float %?92.4%
P/E Ratio?109.92
P/B Ratio?5.12
EPS?$0.32
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?5.03Strong
Quick Ratio?4.68Strong
Cash Ratio?2.04Strong
Debt/Equity?0.00Low
ValuationRICHLY VALUED
Score44/100
P/E?109.9PRICEY▾
P/B?5.12FAIR▾
P/S?6.57FAIR▾
P/FCF?73.4PRICEY▾
EV/EBITDA?76.0HIGH▾
EV/Sales?6.21HIGH▾
Returns & Efficiency
ROE?4.7%WEAK▾
ROA?3.4%FAIR▾
Cash Flow & Enterprise
FCF?$24.7M
Enterprise Value?$1.7B
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
Employees
398
Market Cap
1.8B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
1997-02-04
Address
64 SIDNEY ST.
CAMBRIDGE, MA 02139
Phone: (734) 930-5555
CAMBRIDGE, MA 02139
Phone: (734) 930-5555